Celastrol, a potent antioxidant and anti-inflammatory drug, as a possible treatment for Alzheimer's disease
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
In the brains of patients with Alzheimer's disease (AD) signs of neuronal degeneration are accompanied by markers of microglial activation, inflammation, and oxidant damage. The presence of nitrotyrosine in the cell bodies of neurons in AD suggests that peroxynitrite contributes to the pathogenesis of the disease. A drug with antioxidant and anti-inflammatory activity may prevent neuronal degeneration in AD. Celastrol, a plant-derived triterpene, has these effects. In low nanomolar concentrations celastrol was found to suppress the production by human monocytes and macrophages of the pro-inflammatory cytokines TNF-alpha and IL-1beta. Celastrol also decreased the induced expression of class II MHC molecules by microglia. In macrophage lineage cells and endothelial cells celastrol decreased induced but not constitutive NO production. Celastrol suppressed adjuvant arthritis in the rat, demonstrating in vivo anti-inflammatory activity. Low doses of celastrol administered to rats significantly improved their performance in memory, learning and psychomotor activity tests. The potent antioxidant and anti-inflammatory activities of celastrol, and its effects on cognitive functions, suggest that the drug may be useful to treat neurodegenerative diseases accompanied by inflammation, such as AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Nitric oxide: physiology, pathophysiology, and pharmacology.
Moncada, S., Palmer, R. M., & Higgs, E. A. (1991) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06663-3 · Cited by 15,525
Function and Activation of NF-kappaB in the Immune System
Baeuerle, P. A., & Henkel, T. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.001041 · Cited by 4,745
Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue.
McCarthy, K. D., & de Vellis, J. (1980) · The Journal of cell biology · doi:10.1083/jcb.85.3.890 · Cited by 3,845
McGeer, P. L., Schulzer, M., & McGeer, E. G. (1996) · Neurology · doi:10.1212/wnl.47.2.425 · Cited by 1,367
Widespread Peroxynitrite-Mediated Damage in Alzheimer’s Disease
Smith, M. A., Richey Harris, P. L., Sayre, L. M., Beckman, J. S., & Perry, G. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02653.1997 · Cited by 1,239
Sayre, L. M., Zelasko, D. A., Harris, P. L. R., Perry, G., Salomon, R. G., & Smith, M. A. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68052092.x · Cited by 1,007
Oxidative damage in Alzheimer's
Smith, M. A., Perry, G., Richey, P. L., Sayrec, L. M., Anderson, V. E., Beal, M. F., & Kowall, N. (1996) · Nature · doi:10.1038/382120b0 · Cited by 894
Evidence that 4-Hydroxynonenal Mediates Oxidative Stress-Induced Neuronal Apoptosis
Kruman, I., Bruce-Keller, A. J., Bredesen, D., Waeg, G., & Mattson, M. P. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-13-05089.1997 · Cited by 723
Markesbery, W. R., & Lovell, M. A. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00009-8 · Cited by 680
Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress.
Yan, S. D., Chen, X., Schmidt, A. M., Brett, J., Godman, G., Zou, Y. S., Scott, C. W., Caputo, C., Frappier, T., & Smith, M. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.16.7787 · Cited by 565
Research works printed but not linked: 4
- Banati, 1993, Early and Rapid de novo Synthesis of Amyloid 3A4-Amyloid Precursor Protein (APP) in Activated Microglia Glia, 9, 199
- Lei, 1991, Effects of Celastrol on IL-1 and IL-2 Production, Pharmacol. Clin. Chin. Mat. Med., 7, 15
- Lei, 1991, Immune Suppressive Actions of Celastrol, a Triterpene Compound from Tripterygium wilfordii, Pharmacol. Clin. Chin. Mat. Med., 7, 18
- Tao, 1987, Prospective, Controlled, Double-blind Crossover trial of T2 (Polyglycosides Extracted from Tripterygium wilfordii Hook F) in the Treatment of Rheumatoid Arthritis, Chin. J. Med., 26, 399
Cited by
Calabrese, V., Cornelius, C., Dinkova-Kostova, A. T., Calabrese, E. J., & Mattson, M. P. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.3074 · Cited by 796
“Celastrol decreases induced expression of class II MHC molecules by microglia (9).”
Yang, H., Chen, D., Cui, Q. C., Yuan, X., & Dou, Q. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4529 · Cited by 586
Celastrols as Inducers of the Heat Shock Response and Cytoprotection
Westerheide, S. D., Bosman, J. D., Mbadugha, B. N. A., Kawahara, T. L. A., Matsumoto, G., Kim, S., Gu, W., Devlin, J. P., Silverman, R. B., & Morimoto, R. I. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409267200 · Cited by 427
Medicinal chemistry and pharmacology of genus Tripterygium (Celastraceae)
Brinker, A. M., Ma, J., Lipsky, P. E., & Raskin, I. (2007) · Phytochemistry · doi:10.1016/j.phytochem.2006.11.029 · Cited by 415
“Neurodegenerative diseases: Celastrol (65) had antioxidant effects and suppressed production of TNF-α, IL-1β, and class II major histocompatibility antigens, which are also produced by activated microglia.”
BackgroundInfluential(2004) · Planta Medica · doi:10.1055/s-2004-815483 · Cited by 409
Metadata
- Authors
- Allison, A. C., Cacabelos, R., Lombardi, V. R. M., Álvarez, X. A., & Vigo, C.
- Corresponding author
- Vigo, Carmen
- Venue
- Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2001-10
- Volume
- 25
- Issue
- 7
- Pages
- 1341-1357
- ISSN
- 0278-5846 (ISSN-L)
- OpenAlex
- W1974682598
- Cited by
- 376
- References
- 32
- Citations by year
- 2026: 9 · 2025: 9 · 2024: 12 · 2023: 16 · 2022: 15 · 2021: 22 · 2020: 21 · 2019: 26 · 2018: 26 · 2017: 22 · 2016: 27 · 2015: 17 · 2014: 26 · 2013: 14 · 2012: 15
- FWCI
- 3.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Progress in Neuro-Psychopharmacology and Biological Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plants and Neuroprotection
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- celastrol, Alzheimer's disease, triterpenoids, antioxidant activity, anti-inflammatory activity, microglial activation, nitrotyrosine, peroxynitrite, TNF-α, IL-1β, MHC class II expression, nitric oxide, adjuvant-induced arthritis, cognitive function, neurodegeneration
- MeSH terms
- Alzheimer Disease, Animals, Anti-Inflammatory Agents, Non-Steroidal, Antioxidants, Humans, Triterpenes, Pentacyclic Triterpenes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Celastrol, a potent antioxidant and anti-inflammatory drug, as a possible treatment for Alzheimer's disease. https://app.cochat.ai/papers/10.1016/s0278-5846(01)00192-0
- The paper
- Allison, A. C., Cacabelos, R., Lombardi, V. R. M., Álvarez, X. A., & Vigo, C. (2001). Celastrol, a potent antioxidant and anti-inflammatory drug, as a possible treatment for Alzheimer's disease. Progress in Neuro-Psychopharmacology and Biological Psychiatry. https://doi.org/10.1016/s0278-5846(01)00192-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.